Trials / Completed
CompletedNCT02346539
Effect of Nicotine on Brain Reward Pathways
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Mclean Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The investigators will determine whether an acute dose of nicotine, in the form of the nicotine lozenge, impacts brain and behavioral measures of mood and reward responsiveness in individuals with major depressive disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nicotine polacrilex | Single Acute dose |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2017-11-01
- Completion
- 2017-11-01
- First posted
- 2015-01-27
- Last updated
- 2018-03-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02346539. Inclusion in this directory is not an endorsement.